, Collaborators The EVOLCAM study group
,
, , p.912
, TransVIHMI
, UCAC
,
,
,
,
,
,
,
,
,
,
, Mbalmayo
, Bikop
,
,
,
, Ngam Engonwei (District Hospital
, District Hospital
, District Hospital
,
,
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between, Lancet, vol.386, pp.1546-55, 1965. ,
Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis, J Viral Hepat, vol.23, pp.244-55, 2016. ,
Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach, J Hepatol, vol.62, pp.469-76, 2015. ,
Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses, Trop Med Int Health, vol.13, pp.744-53, 2008. ,
Battlefield against hepatitis B infection and HCC in Africa, J Hepatol, vol.66, pp.645-54, 2017. ,
The status of hepatitis B control in the African region, Pan Afr Med J, vol.27, p.3, 2017. ,
, Guidelines on hepatitis B and C testing, 2017.
Conférence internationale des acteurs de lutte contre les hépatites en Afrique francophone, 2011. ,
Rationing hepatitis C treatment in the context of austerity policies in France and Cameroon: A transnational perspective on the pharmaceuticalization of healthcare systems, Soc Sci Med, vol.187, pp.243-50, 2017. ,
Représentations et vécu de l'hépatite B de patients subsahariens en Côte d'Ivoire et en France, Santé Publique, vol.26, pp.869-78, 2014. ,
Barriers to Linkage to Care for Hepatitis B Virus Infection: A Qualitative Analysis in Burkina Faso, West Africa, Am J Trop Med Hyg, vol.95, pp.1368-75, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02548814
Seroprevalence of hepatitis C virus infection in Cameroon: a systematic review and meta-analysis, WHO. World health statistics, vol.7, p.15748, 2015. ,
The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960, Infect Genet Evol, vol.7, pp.361-368, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00542183
Treatment interruption in HIV-positive patients followed up in Cameroon's antiretroviral treatment programme: individual and health care supply-related factors (ANRS-12288 EVOLCam survey), Trop Med Int Health, vol.23, pp.315-341, 2018. ,
Using Grounded Theory Method to Capture and Analyze Health Care Experiences, Health Serv Res, vol.50, pp.1195-210, 2015. ,
, The world health report 2000 -Health systems: improving performance, 1999.
Household catastrophic health expenditure: a multicountry analysis, Lancet, vol.362, pp.111-118, 2003. ,
How to improve access to therapy in hepatitis B patients, Liver Int, vol.38, pp.115-136, 2018. ,
The future of viral hepatitis testing: innovations in testing technologies and approaches, BMC Infect Dis, vol.17, p.699, 2017. ,
Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings, J Viral Hepat, vol.25, pp.108-125, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01651784
, Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, 2017.
Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national crosssectional survey, Bull World Health Organ, vol.87, pp.279-87, 2009. ,
Adherence to HAART: a systematic review of developed and developing nation patientreported barriers and facilitators, PLoS Med, vol.3, p.438, 2006. ,
Cost-effectiveness of Sofosbuvir-Based Hepatitis C regimens in Central and West Africa (ANRS 12342). Oral presentation EASL conference, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02146894
, Progress report on access to hepatitis C treatment: WHO, 2018.
Hepatitis C in Cameroon: What is the progress from 2001 to 2016?, J Transl Int Med, vol.4, pp.162-171, 2016. ,